Atrium Therapeutics, Inc. (RNA)
8.25
-0.15
(-1.79%)
USD |
NASDAQ |
Oct 29, 16:00
8.25
0.00 (0.00%)
After-Hours: 20:00
Atrium Therapeutics Price to Book Value : 0.6576 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 0.6696 |
| October 27, 2026 | 0.6633 |
| October 26, 2026 | 0.6417 |
| October 23, 2026 | 0.6537 |
| October 22, 2026 | 0.6505 |
| October 21, 2026 | 0.6378 |
| October 20, 2026 | 0.6362 |
| October 19, 2026 | 0.6067 |
| October 16, 2026 | 0.6115 |
| October 15, 2026 | 0.6234 |
| October 14, 2026 | 0.6122 |
| October 13, 2026 | 0.6178 |
| October 12, 2026 | 0.6545 |
| October 09, 2026 | 0.6696 |
| October 08, 2026 | 0.6585 |
| October 07, 2026 | 0.6322 |
| October 06, 2026 | 0.637 |
| October 05, 2026 | 0.6354 |
| October 02, 2026 | 0.625 |
| October 01, 2026 | 0.6489 |
| September 30, 2026 | 0.6601 |
| September 29, 2026 | 0.6712 |
| September 28, 2026 | 0.6712 |
| September 25, 2026 | 0.6609 |
| September 24, 2026 | 0.6529 |
| Date | Value |
|---|---|
| September 23, 2026 | 0.6641 |
| September 22, 2026 | 0.735 |
| September 21, 2026 | 0.7326 |
| September 18, 2026 | 0.7135 |
| September 17, 2026 | 0.7621 |
| September 16, 2026 | 0.7573 |
| September 15, 2026 | 0.8044 |
| September 14, 2026 | 0.8139 |
| September 11, 2026 | 0.8259 |
| September 10, 2026 | 0.8251 |
| September 09, 2026 | 0.8379 |
| September 08, 2026 | 0.9048 |
| September 04, 2026 | 1.131 |
| September 03, 2026 | 1.164 |
| September 02, 2026 | 1.121 |
| September 01, 2026 | 1.098 |
| August 31, 2026 | 1.062 |
| August 28, 2026 | 1.087 |
| August 27, 2026 | 1.114 |
| August 26, 2026 | 1.104 |
| August 25, 2026 | 1.116 |
| August 24, 2026 | 1.086 |
| August 21, 2026 | 1.052 |
| August 20, 2026 | 1.075 |
| August 19, 2026 | 1.093 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.5246 |
| Exicure, Inc. | 6.133 |
| Century Therapeutics, Inc. | 1.131 |
| Absci Corp. | 8.434 |
| Celularity, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.161 |
| PEG Ratio | -0.0057 |
| Price | 8.25 |
| Earnings Yield | -55.85% |
| Market Cap | 141.12M |
| PEGY Ratio | -0.0057 |